This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Stefanie Kern: Innovator in Cardiac Diagnostics
Introduction
Stefanie Kern is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of cardiac diagnostics through her innovative research and development of antibodies.
Latest Patents
Stefanie Kern holds a patent for "Antibodies recognizing genetic variants of NT-proBNP." This patent describes an antibody that specifically binds to a mutated NT-proBNP, which includes mutations substituting arginine at position 46 with histidine and substituting glutamic acid at position 43 with aspartic acid. The patent also encompasses a mutated NT-proBNP or its fragments, as well as kits containing the antibody or the mutated NT-proBNP. Furthermore, the disclosure includes a method for diagnosing heart failure.
Career Highlights
Stefanie Kern is currently employed at Roche Diagnostics Operations, Inc., where she continues to advance her research in the field of diagnostics. Her work has been instrumental in developing tools that can aid in the early detection of heart conditions.
Collaborations
Stefanie collaborates with notable colleagues, including Klaus Hallermayer and Monika Soukupova, who contribute to her research efforts and innovations.
Conclusion
Stefanie Kern's work in developing antibodies for cardiac diagnostics exemplifies her commitment to advancing medical technology. Her contributions are vital for improving heart failure diagnosis and treatment options.